Colombia Gut Health Supplements Market Size & Outlook, 2025-2033

Colombia Gut Health Supplements Market Insights

According to Deep Market Insights analysis, the Colombia Gut Health Supplements Market size was USD 80.87 Million in 2024 and is projected to reach USD 192.77 Million by 2033.
The Colombia market is projected to grow at a CAGR of 10.07% between 2026 and 2033.
By segment, Probiotic Strains emerged as the largest Ingredient Type in terms of market size in 2024.
Probiotic Strains is anticipated to remain the most attractive Ingredient Type segment, recording the fastest growth during the forecast period.

In 2024, Colombia accounted for 0.52% of the global Gut Health Supplements Market size.
By 2033, United States is expected to lead the global Gut Health Supplements Market in terms of market size.
Within LATAM, Brazil is projected to dominate the regional Gut Health Supplements Market size by 2033.
Chile is identified as the fastest-growing market in LATAM, anticipated to reach USD 227.65 Million by 2033.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 80.87 Million
Market Size In 2033	USD 192.77 Million
Largest segment	Probiotic Strains
Units	Revenue in USD Million
CAGR	10.07% (2025-2033)
Segmnetation Covered
Ingredient Type	Probiotic Strains Prebiotic Fibers Postbiotic Compounds Digestive Enzymes
Health Benefit	Digestive Balance Immune System Support Inflammation Reduction Metabolic Health Improvement
Dosage Form	Capsules And Tablets Powdered Supplements Liquid Formulations Functional Gummies
Distribution Channel	Pharmacies Online Platforms Health Food Stores Direct To Consumer Sales
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Ingredient Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Probiotic Strains	XX.x	XX.x	XX.x	32.44	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Prebiotic Fibers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Postbiotic Compounds	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Digestive Enzymes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Health Benefit	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Digestive Balance	XX.x	XX.x	XX.x	40.42	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Immune System Support	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Inflammation Reduction	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Metabolic Health Improvement	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Dosage Form	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Capsules And Tablets	XX.x	XX.x	XX.x	39.89	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Powdered Supplements	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid Formulations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Functional Gummies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Distribution Channel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pharmacies	XX.x	XX.x	XX.x	37.77	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online Platforms	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Health Food Stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Direct To Consumer Sales	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x